Here are the 10-K annual reports from Enhabit, Inc. (EHAB) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow EHAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EHAB filings page.
Enhabit, Inc. filed Amendment No. 1 to its annual report to add detailed Part III information on directors, executive officers, corporate governance and 2025 compensation. The filing describes an independent board with four standing committees, a non-executive chair and a code of ethics, insider-trading policy and anti-hedging rules.
For 2025, the Compensation & Human Capital Committee emphasized pay-for-performance. Named executive officers had significant at-risk pay through annual bonuses and long-term equity, including performance-based and time-based restricted stock units. Under the senior management bonus plan, 2025 Adjusted EBITDA of $108.5 million equaled 55% of target, revenue growth of 2.4% was below threshold, and quality metrics were capped by an EBITDA qualifier, leading to a final payout of 50% of target after committee discretion.
The CEO’s 2025 target total direct compensation was $4.42 million, with a large majority in performance-based incentives. Stockholders strongly supported executive pay, with over 98.9% of votes cast approving the 2025 say-on-pay proposal. The company also highlights its Incentive Compensation Recoupment Policy and a supplemental clawback, equity ownership guidelines for leaders and directors, and change-in-control and severance frameworks designed to retain key talent while aligning management with long-term stockholder interests.
Enhabit, Inc. filed its annual report outlining a large, national home health and hospice platform and the growing regulatory and reimbursement complexity it faces. The company operated 249 home health and 117 hospice locations across 34 states as of December 31, 2025, with Home Health generating $813.8 million of net service revenue and Hospice $246.2 million. Medicare and Medicare Advantage together supplied 89.7% of net service revenue, reflecting a steady shift from traditional Medicare to Medicare Advantage. Enhabit highlights clinical quality metrics that beat national averages and a payer innovation strategy focused on value‑based contracts. The filing also describes a proposed all‑cash merger with a Kinderhook affiliate valued at approximately $1.1 billion and details extensive risks that the transaction may be delayed, altered, or not completed.